CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation

CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation

Lysine acetylation is becoming increasingly recognized as a general biological principle in cellular homeostasis, and is subject to abnormal control in different human pathologies. Here, we describe a global effect on amyloid-like protein aggregation in human cells that results from aberrant lysine...

Descripció completa

Dades bibliogràfiques
Autors principals:	Olzscha, H, Fedorov, O, Kessler, B, Knapp, S, La Thangue, N
Format:	Journal article
Idioma:	English
Publicat:	Cell Press 2016

Ítems similars

Bromodomains control amyloid-like aggregation of aberrantly acetylated proteins
per: Olzscha, H, et al.
Publicat: (2018)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
per: Popp, T, et al.
Publicat: (2016)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
per: Hay, D, et al.
Publicat: (2014)

Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
per: Picaud, S, et al.
Publicat: (2015)

Targeting bromodomains: epigenetic readers of lysine acetylation.
per: Filippakopoulos, P, et al.
Publicat: (2014)

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
per: Hammitzsch, A, et al.
Publicat: (2015)

CBP/p300 bromodomain: new promising epigenetic target
per: Xiang Qiuping, et al.
Publicat: (2022-01-01)

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation
per: Ryan Raisner, et al.
Publicat: (2018-08-01)

Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming
per: Ebrahimi, A, et al.
Publicat: (2019)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
per: Hewings, D, et al.
Publicat: (2011)

3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands
per: Hewings, D, et al.
Publicat: (2011)

Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation
per: Denise E. de Almeida Nagata, et al.
Publicat: (2019-04-01)

Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites.
per: Vidler, L, et al.
Publicat: (2012)

Epigenetic mechanisms to propagate histone acetylation by p300/CBP
per: Masaki Kikuchi, et al.
Publicat: (2023-07-01)

Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP.
per: Crump, N, et al.
Publicat: (2011)

Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.
per: Hewings, D, et al.
Publicat: (2012)

Dissecting the role of CBP/P300-mediated acetylation in enhancer function
per: Jackson, N
Publicat: (2023)

Cracking the histone code: Developing inhibitors of bromodomain-acetyl-lysine interactions
per: Conway, S
Publicat: (2013)

Transcriptional synergy in human aortic endothelial cells is vulnerable to combination p300/CBP and BET bromodomain inhibition
per: Ronan C. Bracken, et al.
Publicat: (2024-06-01)

Differential contribution of p300 and CBP to regulatory element acetylation in mESCs
per: Sara Martire, et al.
Publicat: (2020-07-01)

CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells
per: Riley M. Horvath, et al.
Publicat: (2024-12-01)

The CBP-1/p300 Lysine Acetyltransferase Regulates the Heat Shock Response in C. elegans
per: Lindsey N. Barrett, et al.
Publicat: (2022-04-01)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
per: Andrew R Conery, et al.
Publicat: (2016-01-01)

P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer
per: Yin‐Wei Cheng, et al.
Publicat: (2021-12-01)

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
per: Andrew R Conery, et al.
Publicat: (2016-07-01)

p300/CBP and Lung Cancer
per: Enwang WANG, et al.
Publicat: (2009-08-01)

ATRA transcriptionally induces nSMase2 through CBP/p300-mediated histone acetylation[S]
per: Christopher J. Clarke, et al.
Publicat: (2016-05-01)

E2F1 acetylation directs p300/CBP-mediated histone acetylation at DNA double-strand breaks to facilitate repair
per: Swarnalatha Manickavinayaham, et al.
Publicat: (2019-10-01)

The therapeutic potential of acetyl-lysine and methyl-lysine effector domains
per: Brennan, P, et al.
Publicat: (2012)

The therapeutic potential of acetyl-lysine and methyl-lysine effector domains
per: Brennan, P, et al.
Publicat: (2012)

The histone acetyl transferases CBP and p300 regulate stress response pathways in synovial fibroblasts at transcriptional and functional levels
per: Monika Krošel, et al.
Publicat: (2023-10-01)

Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition
per: Emily Hsu, et al.
Publicat: (2021-03-01)

A Read/Write Mechanism Connects p300 Bromodomain Function to H2A.Z Acetylation
per: Yolanda Colino-Sanguino, et al.
Publicat: (2019-11-01)

Targeting CBP and p300: Emerging Anticancer Agents
per: Domiziana Masci, et al.
Publicat: (2024-09-01)

Lysine Acetyltransferase p300/CBP Plays an Important Role in Reproduction, Embryogenesis and Longevity of the Pea Aphid <i>Acyrthosiphon pisum</i>
per: Phillipp Kirfel, et al.
Publicat: (2020-04-01)

Molecular Lysine Tweezers Counteract Aberrant Protein Aggregation
per: Inesa Hadrovic, et al.
Publicat: (2019-10-01)

Alterations of Lysine Acetylation Profile in Murine Skeletal Muscles Upon Exercise
per: Dehuan Liang, et al.
Publicat: (2022-05-01)

Discovery of pyrrolo[3,2-d]pyrimidin-4-one derivatives as a new class of potent and cell-active inhibitors of P300/CBP-associated factor bromodomain
per: Huang, L, et al.
Publicat: (2019)

Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis.
per: Cohen, H, et al.
Publicat: (2004)

CBP/p300 as a co-factor for the Microphthalmia transcription factor.
per: Sato, S, et al.
Publicat: (1997)